Pages that link to "Q36817686"
Jump to navigation
Jump to search
The following pages link to Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. (Q36817686):
Displaying 50 items.
- Blood pressure control for diabetic retinopathy (Q24186434) (← links)
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy (Q24187858) (← links)
- Laser photocoagulation for proliferative diabetic retinopathy (Q24187871) (← links)
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy (Q24236189) (← links)
- Blood pressure control for diabetic retinopathy (Q24245872) (← links)
- Epidemiological issues in diabetic retinopathy (Q27003941) (← links)
- Does tight control of systemic factors help in the management of diabetic retinopathy? (Q28074223) (← links)
- Diabetic retinopathy and systemic factors (Q28082046) (← links)
- Preventing diabetic retinopathy through control of systemic factors (Q28166089) (← links)
- Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes (Q28210667) (← links)
- Screening for and managing diabetic retinopathy: current approaches (Q28220190) (← links)
- How can we improve the management of vascular risk in type 2 diabetes: insights from FIELD (Q28258705) (← links)
- Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study (Q28661253) (← links)
- Diabetic macular oedema: clinical risk factors and emerging genetic influences. (Q30234323) (← links)
- Fenofibrate and Diabetic Retinopathy (Q30248492) (← links)
- PPARalpha: an emerging therapeutic target in diabetic microvascular damage. (Q30390555) (← links)
- Ocular disease in the diabetic elderly. (Q30640153) (← links)
- Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system (Q30821870) (← links)
- The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study (Q30934358) (← links)
- Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial. (Q31018013) (← links)
- View 1: should this patient receive laser treatment? (Q31049544) (← links)
- The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark (Q31104469) (← links)
- The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? (Q31119010) (← links)
- Changing times for the management of diabetic retinopathy (Q31123332) (← links)
- Clinical outcomes following laser photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital (Q31150631) (← links)
- Diabetic retinopathy: should this patient receive laser treatment? Overview (Q33198523) (← links)
- Risk factors for diffuse and focal macular edema (Q33203984) (← links)
- Current and future pharmacological intervention for diabetic retinopathy. (Q33216425) (← links)
- Risk factors for diabetic macular edema (Q33230953) (← links)
- Diabetic eye disease. (Q33231783) (← links)
- Diabetic macular oedema: a clinical overview (Q33269486) (← links)
- Diabetic retinopathy: treatment and prevention (Q33302529) (← links)
- Emerging pharmacotherapies for diabetic macular edema (Q33304852) (← links)
- Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. (Q33305306) (← links)
- Diabetic retinopathy: an update (Q33328784) (← links)
- Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial (Q33368822) (← links)
- Emerging drugs for diabetic retinopathy (Q33388498) (← links)
- Ocular telehealth initiatives in diabetic retinopathy (Q33488380) (← links)
- Pharmacologic therapies for diabetic retinopathy and diabetic macular edema (Q33492340) (← links)
- Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy? (Q33522560) (← links)
- Selective retina therapy (SRT) for clinically significant diabetic macular edema (Q33555931) (← links)
- Biomarkers in Diabetic Retinopathy (Q33583030) (← links)
- Effects of medical therapies on retinopathy progression in type 2 diabetes (Q33620031) (← links)
- Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema (Q33645419) (← links)
- Multimodality analysis of Hyper-reflective Foci and Hard Exudates in Patients with Diabetic Retinopathy (Q33685610) (← links)
- The Role of Systemic Risk Factors in Diabetic Retinopathy (Q33689773) (← links)
- Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema (Q33706098) (← links)
- Current and future management of diabetic retinopathy: a personalized evidence-based approach (Q33738829) (← links)
- Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy. (Q33740088) (← links)
- Lipids, lipid-lowering therapy and diabetes complications (Q33761978) (← links)